Agios Pharm (AGIO) Misses Q2 EPS by 13c

Agios Pharm (NASDAQ: AGIO) reported Q2 EPS of ($0.54), $0.13 worse than the analyst estimate of ($0.41). Revenue for the quarter came in at $8.41 million versus the consensus estimate of $11 million.

For earnings history and earnings-related data on Agios Pharm (AGIO) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Bit Digital (BTBT) Misses Q2 EPS by 27c
• Bernstein SocGen on Performance Food Group (PFGC): 'Not the quarter we were hoping for, but LT story intact'